The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response
Open accessAbstract
African green monkeys (AGMs) infected with the AGM type of SIV (SIVagm) do not develop chronic immune activation and AIDS, despite viral loads similar to those detected in humans infected with HIV-1 and rhesus macaques (RMs) infected with the RM type of SIV (SIVmac). Because chronic immune activation drives progressive CD4+ T cell depletion and immune cell dysfunctions, factors that characterize disease progression, we sought to understand the molecular basis of this AGM phenotype. To this end, we longitudinally assessed the gene expression profiles of blood- and lymph node-derived CD4+ cells from AGMs and RMs in response to SIVagm and SIVmac infection, respectively, using a genomic microarray platform. The molecular signature of acute infection was characterized, in both species, by strong upregulation of type I IFN-stimulated genes (ISGs). ISG expression returned to basal levels after postinfection day 28 in AGMs but was sustained in RMs, especially in the lymph node-derived cells. We also found that SIVagm induced IFN-alpha production by AGM cells in vitro and that low IFN-alpha levels were sufficient to induce strong ISG responses. In conclusion, SIV infection triggered a rapid and strong IFN-alpha response in vivo in both AGMs and RMs, with this response being efficiently controlled only in AGMs, possibly as a result of active regulatory mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
PANTHER: A Library of Protein Families and Subfamilies Indexed by Function
Thomas, P. D., Campbell, M. J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A., & Narechania, A. (2003) · Genome Research · doi:10.1101/gr.772403 · Cited by 2,944
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,033
Deeks, S. G., Kitchen, C. M. R., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P., Martin, J. N., Kahn, J. O., Levy, J., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 804
Persistent immune activation in HIV-1 infection is associated with progression to AIDS
Hazenberg, M. D., Otto, S. A., van Benthem, B. H., Roos, M. T., Coutinho, R. A., Lange, J. M., Hamann, D., Prins, M., & Miedema, F. (2003) · AIDS · doi:10.1097/00002030-200309050-00006 · Cited by 773
Stacey, A. R., Norris, P. J., Qin, L., Haygreen, E. A., Taylor, E., Heitman, J., Lebedeva, M., DeCamp, A., Li, D., Grove, D., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01844-08 · Cited by 747
IL-10–producing and naturally occurring CD4+ Tregs: limiting collateral damage
O’Garra, A., Vieira, P. L., Vieira, P., & Goldfeld, A. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423215 · Cited by 529
Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P., Stritesky, G. L., Kaplan, M. H., Waisman, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809850105 · Cited by 508
Sousa, A. E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z., & Victorino, R. M. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3400 · Cited by 507
Bosinger, S. E., Li, Q., Gordon, S. N., Klatt, N. R., Duan, L., Xu, L., Francella, N., Sidahmed, A., Smith, A. J., Cramer, E. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40115 · Cited by 409
Self-citationFavre, D., Lederer, S., Kanwar, B., Ma, Z.-M., Proll, S., Kasakow, Z., Mold, J., Swainson, L., Barbour, J. D., Baskin, C. R., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000295 · Cited by 405
Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity
McKenna, K., Beignon, A.-S., & Bhardwaj, N. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.17-27.2005 · Cited by 394
Mandl, J. N., Barry, A. P., Vanderford, T. H., Kozyr, N., Chavan, R., Klucking, S., Barrat, F. J., Coffman, R. L., Staprans, S. I., & Feinberg, M. B. (2008) · Nature Medicine · doi:10.1038/nm.1871 · Cited by 383
Baskin, C. R., Bielefeldt-Ohmann, H., Tumpey, T. M., Sabourin, P. J., Long, J. P., García-Sastre, A., Tolnay, A.-E., Albrecht, R., Pyles, J. A., Olson, P. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813234106 · Cited by 361
Fonteneau, J.-F., Larsson, M., Beignon, A.-S., McKenna, K., Dasilva, I., Amara, A., Liu, Y.-J., Lifson, J. D., Littman, D. R., & Bhardwaj, N. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5223-5232.2004 · Cited by 351
Gordon, S. N., Klatt, N. R., Bosinger, S. E., Brenchley, J. M., Milush, J. M., Engram, J. C., Dunham, R. M., Paiardini, M., Klucking, S., Danesh, A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3026 · Cited by 286
Self-citationEstaquier, J., Idziorek, T., de Bels, F., Barré-Sinoussi, F., Hurtrel, B., Aubertin, A. M., Venet, A., Mehtali, M., Muchmore, E., & Michel, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9431 · Cited by 249
Self-citationEstes, J. D., Li, Q., Reynolds, M. R., Wietgrefe, S., Duan, L., Schacker, T., Picker, L. J., Watkins, D. I., Lifson, J. D., Reilly, C., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/500368 · Cited by 237
Chronic innate immune activation as a cause of HIV-1 immunopathogenesis
Boasso, A., & Shearer, G. M. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.08.015 · Cited by 206
Interferons: Signaling, antiviral and viral evasion
Bonjardim, C. A., Ferreira, P. C. P., & Kroon, E. G. (2009) · Immunology Letters · doi:10.1016/j.imlet.2008.11.002 · Cited by 196
HIV-1 immunopathogenesis: How good interferon turns bad
Herbeuval, J.-P., & Shearer, G. M. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.09.016 · Cited by 190
Hyrcza, M. D., Kovacs, C., Loutfy, M., Halpenny, R., Heisler, L., Yang, S., Wilkins, O., Ostrowski, M., & Der, S. D. (2007) · Journal of Virology · doi:10.1128/jvi.01552-06 · Cited by 190
Tailor, P., Tamura, T., Kong, H. J., Kubota, T., Kubota, M., Borghi, P., Gabriele, L., & Ozato, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.009 · Cited by 180
Diop, O. M., Gueye, A., Dias-Tavares, M., Kornfeld, C., Faye, A., Ave, P., Huerre, M., Corbet, S., Barre-Sinoussi, F., & Müller-Trutwin, M. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7538-7547.2000 · Cited by 165
Malleret, B., Manéglier, B., Karlsson, I., Lebon, P., Nascimbeni, M., Perié, L., Brochard, P., Delache, B., Calvo, J., Andrieu, T., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162651 · Cited by 163
Self-citationLederer, S., Favre, D., Walters, K., Proll, S. C., Kanwar, B., Kasakow, Z., Baskin, C. R., Palermo, R. E., McCune, J. M., & Katze, M. G. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000296 · Cited by 141
Diop, O. M., Ploquin, M. J.-Y., Mortara, L., Faye, A., Jacquelin, B., Kunkel, D., Lebon, P., Butor, C., Hosmalin, A., Barré‐Sinoussi, F., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02433-07 · Cited by 130
Self-citationMüller-Trutwin, M. C., Saksena, N. K., Nerrienet, E., Chappey, C., Hervé, V. M., Durand, J. P., Legal-Campodonico, P., Lang, M.-C., Digoutte, J. P., & Georges, A. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1227-1235.1993 · Cited by 126
Self-citationGiavedoni, L. D. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.03.015 · Cited by 124
Self-citationGene Expression Profiling of Host Response in Models of Acute HIV Infection
Bosinger, S. E., Hosiawa, K. A., Cameron, M. J., Persad, D., Ran, L., Xu, L., Boulassel, M. R., Parenteau, M., Fournier, J., Rud, E. W., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6858 · Cited by 98
Type I interferon production in HIV-infected patients
Hosmalin, A., & Lebon, P. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306154 · Cited by 82
Self-citationJähn, P., Zaenker, K. S., Schmitz, J., & Dzionek, A. (2008) · European Journal of Immunology · doi:10.1002/eji.200737552 · Cited by 78
Foley, J. F., Yu, C., Solow, R., Yacobucci, M., Peden, K., & Farber, J. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4892 · Cited by 72
Liovat, A.-S., Jacquelin, B., Ploquin, M. J.-Y., Barré‐Sinoussi, F., & Müller-Trutwin, M. C. (2009) · Current HIV Research · doi:10.2174/157016209787048546 · Cited by 72
Self-citationGeorge, M. D., Sankaran, S., Reay, E., Gelli, A., & Dandekar, S. (2003) · Virology · doi:10.1016/s0042-6822(03)00207-1 · Cited by 69
Ploquin, M. J.-Y., Desoutter, J.-F., dos Santos, P. R., Pandrea, I., Diop, O. M., Hosmalin, A., Butor, C., Barré‐Sinoussi, F., & Müller-Trutwin, M. C. (2006) · Retrovirology · doi:10.1186/1742-4690-3-37 · Cited by 44
Self-citationGeneration of CD3+CD8low Thymocytes in the HIV Type 1-Infected Thymus
Keir, M. E., Rosenberg, M. G., Sandberg, J. K., Jordan, K. A., WIZNIA, A. A., Nixon, D. F., Stoddart, C. A., & McCune, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2788 · Cited by 41
Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection
van Asten, L., Danisman, F., Otto, S. A., Borghans, J. A. M., Hazenberg, M. D., Coutinho, R. A., Prins, M., & Miedema, F. F. (2004) · AIDS · doi:10.1097/00002030-200409240-00004 · Cited by 37
Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4+ T Cells
Audigé, A., Urosevic, M., Schlaepfer, E., Walker, R., Powell, D., Hallenberger, S., Joller, H., Simon, H., Dummer, R., & Speck, R. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6227 · Cited by 36
Noth, S., Benecke, A., & systems epigenomics group (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-307 · Cited by 34
Self-citationNoth, S., Brysbaert, G., & Benecke, A. (2006) · Genomics Proteomics & Bioinformatics · doi:10.1016/s1672-0229(06)60021-1 · Cited by 33
Self-citationNoth, S., Brysbaert, G., Pellay, F., & Benecke, A. (2006) · Genomics Proteomics & Bioinformatics · doi:10.1016/s1672-0229(07)60002-3 · Cited by 26
Self-citationPhenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes
Mortara, L., Ploquin, M. J.-Y., Faye, A., Scott‐Algara, D., Vaslin, B., Butor, C., Hosmalin, A., Barré‐Sinoussi, F., Diop, O. M., & Müller-Trutwin, M. C. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.10.005 · Cited by 20
Self-citationLong oligonucleotide microarrays for African green monkey gene expression profile analysis
Jacquelin, B., Mayau, V., Brysbaert, G., Regnault, B., Diop, O. M., Arenzana‐Seisdedos, F., Rogge, L., Coppée, J., Barré‐Sinoussi, F., Benecke, A., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8271com · Cited by 17
Self-citation
Cited by
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Persistent LCMV infection is controlled by blockade of type I interferon signaling
Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A. (2013) · Science · doi:10.1126/science.1235214 · Cited by 755
The dual nature of type I and type II interferons
Lee, A. J., & Ashkar, A. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02061 · Cited by 690
Blockade of chronic type I interferon signaling to control persistent LCMV infection
Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G. (2013) · Science · doi:10.1126/science.1235208 · Cited by 709
Type I Interferon in Chronic Virus Infection and Cancer
Snell, L. M., McGaha, T. L., & Brooks, D. G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.05.005 · Cited by 500
Metadata
- Authors
- Jacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M.-A., Roques, P., Butor, C., Silvestri, G., Giavedoni, L. D., Lebon, P., Barré-Sinoussi, F., Benecke, A., & Müller-Trutwin, M. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-11-23
- Volume
- 119
- Issue
- 12
- Pages
- 3544-55
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2104586170
- Cited by
- 481
- References
- 46
- FWCI
- 15.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.